secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-08-22T23:59:59+00:00
Accession:  0001213900-25-079504
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital enters $20M PIPE at $16/share and 12M share escrow for Semnur merger
--------------------------------------------------------------------------------

- PIPE purchase of 1.25M shares at $16.00 each for $20M total from a single purchaser.
- Shares sold exempt under Section 4(a)(2) and Rule 506(b); restricted securities.
- Semnur to deposit 12M shares of New Semnur common stock into escrow within 20 business days post-closing.
- Closing conditioned on business combination; termination date for PIPE is Dec 31, 2025.
- Merger agreement (amended) with Denali Merger Sub Inc. and Semnur; S-4 effective Aug 12, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025079504/0001213900-25-079504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025079504/ea0254236-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-079504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer